The Effect of Patient Discharge From the Maternal and Fetal Medicine Unit With Receiving a Discharge Letter Later Using the Apollo App on Discharge Data, Safety and Patient Satisfaction

September 17, 2024 updated by: The Baruch Padeh Medical Center, Poriya

The Effect of Patient Discharge From the Maternal and Fetal Medicine Unit With Receiving a Discharge Letter Later Using the Apollo App on Discharge Data, Safety and Patient Satisfaction - a Prospective Randomized Controlled Trial

Women admitted to the maternal and fetal medicine unit are often discharged after a short hospital stay. The routine work in the department is prioritized such that the discharge letter are written. In the last year the Apollo mobile application (app) was introduced. It contains general information on the medical center and the maternal and fetal unit department as well as the medical records, laboratory results and summary and discharge letters. The Apollo app is used in the maternal and fetal unit in the discharge process so the patient can receive the discharge letter in the app and does not need to wait until the discharge letter is written.

It is not known whether this process is more effective than the regular discharge process and patients' satisfaction was not assessed previously.

In the present study we will compare discharge data, satisfaction and safety of discharging using the Apollo app versus the routine process.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

140

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • North
      • Tiberias, North, Israel, 15208
        • Recruiting
        • Tzafon Medical center, Poriya
        • Contact:
          • Enav Yefet, MD/PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Women who are admitted to the maternal and fetal medicine unit with the intention to be discharged before delivery
  • 18 years old and older
  • Consent to participate
  • Owner of a smart phone
  • Consent to download the Apollo app

Exclusion Criteria:

  • Delivery during her admission
  • Doesn't own a smart phone
  • Refusal to download to Apollo app
  • Refusal to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Application discharge
The discharge is conditional on the approval of a senior physician or the attending physician in charge. The participant will sign on a "Form for discharge and consent to receive a discharge letter, using the "Apollo" application" in which the discharge process, recommendations and contact information of the department are described. Thereafter, the patient will be discharge home and the discharge letter will be available in the app once it is written. The participant is guided to contact the department, in case the discharge letter is not received in the application up to 24 hours after discharge.
Discharge using Apollo application
Other: Regular discharge
The discharge is conditional on the approval of a senior physician or the attending physician in charge. The patient will go home only after the discharge letter is written.
Discharge with the regular process

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The mean time needed from discharge decision until the actual discharge
Time Frame: up to 24 hours from discharge decision
up to 24 hours from discharge decision

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction rate from the discharge method
Time Frame: Within a week following discharge from the department
Satisfaction rate from the discharge method assessment using a questionnaire
Within a week following discharge from the department
The rate of participants with any technical difficulties to receive the discharge letter and reasons
Time Frame: Within a week following discharge from the department using a questionnaire
The rate of participants with any technical difficulties to receive the discharge letter and reasons using a questionnaire
Within a week following discharge from the department using a questionnaire
The rate of participants with missed information that required the patient to seek medical help
Time Frame: Within a week following discharge from the department using a questionnaire
The rate of participants with missed information that required the patient to seek medical help using a questionnaire
Within a week following discharge from the department using a questionnaire
The rate of participants with discrepancies between the discharge recommendations written in the final discharge letter and the "Form for discharge and consent to receive a discharge letter, using application" and details regarding the discripancies
Time Frame: Within a week following discharge from the department
Within a week following discharge from the department

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 30, 2024

Primary Completion (Estimated)

August 5, 2025

Study Completion (Estimated)

September 5, 2025

Study Registration Dates

First Submitted

August 11, 2024

First Submitted That Met QC Criteria

September 17, 2024

First Posted (Estimated)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 17, 2024

Last Verified

August 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 55-24-POR

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Patient Satisfaction

Clinical Trials on Discharge using Apollo application

Subscribe